Other Issues

CHPA opposes mandatory manufacturer-funded drug take-back programs as they threaten the affordability of OTC medications that consumers rely on as the first line of defense against common ailments.

To address increasing member demand for products and services related to Generative AI and its applications to your business, we have compiled a list of CHPA member companies who have AI-related capabilities and who are ready to help you on your journey. These capabilities range from model building and implementation to applications in the switch process. Read on for a snapshot of our members' capabilities, and prepare your business for a future of possibilities, efficiencies, and success.

Learn about rules and regulations for structured product labeling of OTC medicines.

CHPA encourages state and local lawmakers to refrain from creating new legislation addressing green chemistry in pharmaceuticals, and instead rely on the rigorous guidelines and standards already implemented at the federal level by agencies like the FDA.

The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.